JORDAN A HENDERSON
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology MYRTLE BEACH, SC NPI 1013200328
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology SC NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$5,622.18
- Category: General Payments
- Program years: PY2018–2024
- Record count: 268
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,177.31 across 43 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $794.88 | 39 |
| Long term medical supply or device loan | $382.43 | 4 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $543.20 | 8 |
| E.R. Squibb & Sons, L.L.C. | $151.31 | 12 |
| Celgene Corporation | $93.43 | 5 |
| JAZZ PHARMACEUTICALS INC. | $54.24 | 2 |
| ABBVIE INC. | $36.51 | 2 |
| Merck Sharp & Dohme Corporation | $35.38 | 2 |
| Genentech USA, Inc. | $34.90 | 2 |
| Novocure Inc. | $33.75 | 1 |
| Daiichi Sankyo Inc. | $29.45 | 1 |
| Janssen Biotech, Inc. | $26.39 | 1 |
| Gilead Sciences, Inc. | $25.09 | 1 |
| PharmaEssentia USA Corporation | $24.10 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.06 | 1 |
| Alnylam Pharmaceuticals Inc. | $20.61 | 1 |
| Incyte Corporation | $17.71 | 1 |
| ARRAY BIOPHARMA INC | $16.31 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $13.87 | 1 |
By program year
Records — PY2024 (43)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.